US Pharmacovigilance Market to Witness an Impressive CAGR until 2025
Increasing rate of drug development and rising cases of adverse drug reactions to drive United States pharmacovigilance market According to TechSci Research report, “ United States Pharmacovigilance Market By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End-User (Hospitals, Research Organizations, Industries), By Region, Forecast & Opportunities, 2025 ” , the market is expected to undergo robust growth during the forecast period owing to the increasing number of new drug developments, which are creating the need for pharmacovigilance. The changing lifestyle patterns among the population has led to lack of proper diets and prevalence of various chronic diseases including cancer and diabetes. This has escalated the consumption of pharmaceutical...